Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

SHOR, RIGL, SMOD, PWRM, AVOT- Stock Update From Stock-PR.com

Stock-PR Reporting

stockpr_logo-site

FREE Daily Stock Alerts From Stock-PR.com

chartstockalert

________________________________________

American Video Teleconferencing Corp. (OTCPK:AVOT) is pleased to announce that it has hired a French speaking geologist to search the archives of the Quebec Department of Mines for Rare Earths showings not on a current computer file. AVOT believes the rare earths industry is where it wants to maintain a very strong focus and is looking to expand its holdings. As neither the Federal nor Quebec Governments have carried out any air borne surveys in this area, AVOT will seek a contractor to do an air borne Mag-EM radiometric survey. This survey will cover its present holdings and the immediate surrounding area looking for future acquisitions. We are pleased to be working in the Province of Quebec as it is rated the number one jurisdiction in the world to carry out mineral exploration. The Quebec Government gives a rebate up to 45% for property expenditures.

China has been one of the main supplier to the US of the Earth's rare mineral supplies, with these rare minerals American manufacturers are able to make high-tech products such as cell phones, wind turbines, and guided missiles, but all that might come to a screeching halt now that China has stopped supplying the material, the New York Times has reported.

In the wake of China's decision America now must look for other sources, that will be more reliable for our future needs, and AVOT may just be the new source, here's why.

AVOT believes the rare earths industry is where it wants to maintain a very strong focus and is looking to expand its holdings. AVOT is currently looking for these Rare Earths Minerals in Canada, the US's Northern neighbor.

AVOT is seeking a contractor to do an air borne Mag-EM radiometric survey for its present holdings and the immediate surrounding area looking for future acquisitions. AVOT is pleased to be working in the Province of Quebec as it is rated the number one jurisdiction in the world to carry out mineral exploration. The Quebec Government gives a rebate up to 45% for property expenditures.

Presently AVOT is in the final stage of negotiations with Kondor Gold Pyt. in Australia.

AVOT is aggressively carrying out searches world-wide for opportunities in Precious, Base and Rare Earths metal projects.

**********************************************

Power3 Medical Products, Inc. (OTC:PWRM)

PWRM recently delivered four poster presentations at the 2010 ICAD. These presentations discussed PWRM’s diagnostic test, NuroPro, and focused on PWRM’s Alzheimer’s disease blood serum biomarkers, test and clinical validation trials.

“In preparation for commercialization, our objective at this meeting was to show how Power3 ’s protein biomarkers and blood tests provide superior solutions for diagnosis and drug response to improve the treatment of Alzheimer’s disease,” stated Dr. Ira L. Goldknopf, PWRM ’s President & Chief Scientific Officer. “It was gratifying to receive substantial attention to our posters from representatives of major pharma and clinical research institutions from around the world. They expressed surprise and enthusiasm for our findings, especially those relating to the methods by which Power3’s protein biomarkers indicate how patients respond to treatment with the three major anti-dementia drugs.”

“We are pleased that our blood tests specifically diagnose Alzheimer’s in patients, both pre- and post-treatment,” commented Helen R. Park, MS, CEO of PWRM, “and that our scientific collaborators, Dr. Marwan Sabbagh, Medical and Scientific Director of the Banner Sun Health Medical Research Institute, and Dr. Lourdes R. Bosquez, President of the Woodlands Behavioral Institute, Inc., presented along with us at the meeting in Hawaii.”

“We are within striking distance of realizing an Alzheimer’s clinical diagnostic tool which I hope will lead to a greater understanding of the disease and buoy the pace of future therapeutic interventions,” added Marwan Sabbagh MD, Medical and Scientific Director of Banner Sun Health Medical Research Institute.

PWRM has filed several patent applications that are currently pending for its NuroPro technology. PWRM also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, PWRM has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China. PWRM has also published 6 articles on NuroPro in peer-reviewed scientific journals. PWRM intends to publish these latest findings as well.

**********************************************

SMART Modular Technologies (WWH) Inc. (Nasdaq:SMOD) a leading independent manufacturer of memory modules and solid state storage products, announced that it plans to release its financial results for the first quarter of fiscal 2011 after the market closes on Thursday, December 16, 2010. The Company will host a corresponding conference call at 1:30 p.m. Pacific Time (NYSE:PT), 4:30 p.m. Eastern Time (NYSE:ET).The conference call will be hosted by Iain MacKenzie, President and Chief Executive Officer, and Barry Zwarenstein, Senior Vice President and Chief Financial Officer. The call may be accessed US toll free by calling +1-877-941-4774 or US toll by calling +1-480-629-9760. Please join the conference call at least ten minutes early and use the access code 4390981. A replay of the conference call will be available until December 30, 2010.

SMART Modular Technologies (WWH), Inc. designs, manufactures, and supplies value added subsystems to original equipment manufacturers worldwide. Its subsystem products include memory modules; solid state drives (NYSE:SSD); and embedded computing and thin film transistor-liquid crystal display (TFT-LCD) products. The company operates in two segments, namely Memory, Display, and Embedded segment, and Adtron segment.

**********************************************

Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) announced that it received the Licensing Deal of the Year award from Scrip Intelligence at the Sixth Annual Scrip Awards last month. The Award, presented jointly to Rigel and AstraZeneca, recognizes the significance of the collaboration forged by the companies to develop fostamatinib (previously referred to as R788) as a novel oral treatment for rheumatoid arthritis (NYSE:RA). This is the first award of its kind given by Scrip to acknowledge the vital importance of licensing to the pharmaceutical industry’s R&D strategies.

Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases.

**********************************************

ShoreTel, Inc. (Nasdaq:SHOR) the leading provider of brilliantly simple IP phone systems with fully integrated unified communications (UC), announced that nonprofit organizations around the world are using ShoreTel to dramatically cut their communications costs and increase operational efficiency and worker productivity in time for the holidays. Organizations like Big Brothers Big Sisters of North Texas, Compassion Australia, United Way, and Heifer International, can focus more donations and resources on carrying out their missions to end hunger and provide more children with a quality education, thanks to ShoreTel’s low total cost of ownership.

ShoreTel, Inc., together with its subsidiaries, provides Internet protocol (NYSE:IP) telecommunications systems for enterprises in the United States. The company systems are based on its distributed software architecture and switch-based hardware platform that enable a single system to serve multi-site enterprises. Its solutions comprise ShoreGear switches, ShorePhone IP phones, and ShoreWare software applications.

**********************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.

Crown Equity Holdings Inc. (OTCPK:CRWE) anticipates to receive 2,000,000 shares of (144) restricted common stock of American Video Teleconferencing Corp. (OTCPK:AVOT) from the company for 12 months IR Services.

Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).

Sign Up For Free Stock Alerts At http://stock-pr.com/signup

http://stock-pr.com/img/stock-pr_buscard.jpg

________________________________________

**********************************************************************

The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.